Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Prevalence of Severe Bacterial Infection in Febrile Children with Sickle CELL Disease in the Era of Pneumococcal Conjugate Vaccine 13

Gloria Contreras-Yametti, MD, Custodio Haidee, MD, Hamayun Imran, MD MSc

Blood (2018) 132 (Supplement 1): 3665.

https://doi.org/10.1182/blood-2018-99-111362

Published: 2018

Journal Articles

Evidence Based Recommendations for Supportive Care in Multiple Myeloma

Anum Qureshi, Muhammad Junaid Tariq, MD, Zunairah Shah, MBBS, Muhammad Abu Zar, MD, Shehroz Aslam, MD, Abdul Rafae, MD, Mustafa Nadeem Malik, MD, Ahmad Kamal, MD, Jemin Aby Jose, MD, Insija Ilyas Selene, MBBS, Madeeha Shafqat, Faiza Jamil, MD, Seren Durer, MD, Ceren Durer, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 1952.

https://doi.org/10.1182/blood-2018-99-110748

Published: 2018

Journal Articles

Safety and Efficacy of Fecal Microbiota Transplantation for Recurrent Clostridium Infection in Patients with Hematologic Malignancies

Mehrdad Hefazi, MD, Mrinal M Patnaik, MBBS, William J Hogan, MBChB, Mark R Litzow, MD, Darrell S Pardi, MD, Sahil Khanna, MBBS

Blood (2016) 128 (22): 3599.

https://doi.org/10.1182/blood.V128.22.3599.3599

Published: 2016

Journal Articles

A Phase Ib/II Study of Ibrutinib in Combination with Obinutuzumab-Gazyva As First-Line Treatment for Patients with Chronic Lymphocytic Leukemia > 65 Years Old or with Coexisting Conditions

Carlos I. Amaya-Chanaga, MD, Michael Y. Choi, MD, Natalie Nguyen, B.Sc, Elizabeth DeVore, B.Sc, Colin MacCarthy, B.Sc, Jacqueline Hilger-Rolfe, PhD, M.S., Thomas J. Kipps, MD, PhD, Januario E. Castro, MD

Blood (2016) 128 (22): 2048.

https://doi.org/10.1182/blood.V128.22.2048.2048

Published: 2016

Journal Articles

A Phase Ib/II Study of Combined Obinutuzumab and High-Dose Methylprednisolone (HDMP) As Treatment for Patients with Chronic Lymphocytic Leukemia (CLL)

Januario E. Castro, MD, Michael Y. Choi, MD, Carlos I. Amaya-Chanaga, MD, Natalie Nguyen, B.Sc, Amine Ale-Ali, PharmD, Thomas J. Kipps, MD, PhD

Blood (2015) 126 (23): 4160.

https://doi.org/10.1182/blood.V126.23.4160.4160

Published: 2015

Journal Articles

A Phase 1 Trial of the Hematopoietic Growth Factor CDX-301 (rhuFlt3L) in Healthy Volunteers

Niroshana Anandasabapathy, MD, PhD, Arlene Hurley, ANP, CCRC, Marina Caskey, Christine Trumpfheller, Popi Sarma, James Pring, Maggie Pack, Renee Riggs, Jennifer Green, Michael Yellin, MD, Thomas A. Davis, MD, Tibor Keler, PhD, Sarah Schlesinger, MD

Blood (2012) 120 (21): 4124.

https://doi.org/10.1182/blood.V120.21.4124.4124

Published: 2012

Journal Articles

Severe Lenalidomide-Induced Hypersensitivity Pneumonitis

Irene A. Dy, M.D., Eric O. Gamboa, MD, Etta Frankel, M.D.

Blood (2010) 116 (21): 4982.

https://doi.org/10.1182/blood.V116.21.4982.4982

Published: 2010

Journal Articles

Cold Hemagglutinin Hemolysis and Hypercoagulable State Due to Mycoplasma Pneumoniae.

Gaurav Gulati, MD, Anthony A Donato, MD, Shuchi Gulati, MD, Daniel A Forman, DO

Blood (2009) 114 (22): 5094.

https://doi.org/10.1182/blood.V114.22.5094.5094

Published: 2009

Journal Articles

RNA Based Cancer Vaccines - Clinical Trials in Patients with Prostate Cancer and Malignant Melanoma.

Gunnar Kvalheim, MD, PhD, Steinar Aamdal, MD, PhD, Gustav Gaudernack, PhD

Blood (2007) 110 (11): 1805.

https://doi.org/10.1182/blood.V110.11.1805.1805

Published: 2007

Journal Articles

A Phase I-II Trial of Bortezomib Plus Oral Cyclophosphamide and Prednisone for Relapsed/Refractory Multiple Myeloma.

Donna E. Reece, MD, Giovanni Piza, MD, Suzanne Trudel, MD, Mariela Pantoja, PhD, Christine Chen, MD, Joseph R. Mikhael, MD, Vishal Kukreti, MD, Keith Stewart, MD

Blood (2006) 108 (11): 3536.

https://doi.org/10.1182/blood.V108.11.3536.3536

Published: 2006

Journal Articles

The Role of Macrophage Migration Inhibitory Factor (MIF) Genetic Polymorphisms in Predicting the Development of Macrocytic Anemia in HIV+ Patients.

Sharon S.J. Lin, BS, Shawn L. Fultz, M.D., M.P.H., Amy C. Justice, M.D., Ph.D., Richard Bucala, M.D., Ph.D., K. Gary J. Vanasse, M.D., Nancy Berliner, M.D.

Blood (2006) 108 (11): 1254.

https://doi.org/10.1182/blood.V108.11.1254.1254

Published: 2006

NARROW

Prevalence of Severe Bacterial Infection in Febrile Children with Sickle CELL Disease in the Era of Pneumococcal Conjugate Vaccine 13

Evidence Based Recommendations for Supportive Care in Multiple Myeloma

Safety and Efficacy of Fecal Microbiota Transplantation for Recurrent Clostridium Infection in Patients with Hematologic Malignancies

A Phase Ib/II Study of Ibrutinib in Combination with Obinutuzumab-Gazyva As First-Line Treatment for Patients with Chronic Lymphocytic Leukemia > 65 Years Old or with Coexisting Conditions

A Phase Ib/II Study of Combined Obinutuzumab and High-Dose Methylprednisolone (HDMP) As Treatment for Patients with Chronic Lymphocytic Leukemia (CLL)

A Phase 1 Trial of the Hematopoietic Growth Factor CDX-301 (rhuFlt3L) in Healthy Volunteers

Severe Lenalidomide-Induced Hypersensitivity Pneumonitis

Cold Hemagglutinin Hemolysis and Hypercoagulable State Due to Mycoplasma Pneumoniae.

RNA Based Cancer Vaccines - Clinical Trials in Patients with Prostate Cancer and Malignant Melanoma.

A Phase I-II Trial of Bortezomib Plus Oral Cyclophosphamide and Prednisone for Relapsed/Refractory Multiple Myeloma.

The Role of Macrophage Migration Inhibitory Factor (MIF) Genetic Polymorphisms in Predicting the Development of Macrocytic Anemia in HIV+ Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only